Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)A Study of DM005 in Patients With Advanced Solid Tumors
Phase 1
Recruiting
- Conditions
- Squamous Cell Carcinoma of Head and NeckCarcinoma, Non-Small-Cell LungSolid Carcinoma
- Interventions
- First Posted Date
- 2024-07-23
- Last Posted Date
- 2025-01-15
- Lead Sponsor
- Doma Biopharmaceutical（Suzhou）Co., Ltd.
- Target Recruit Count
- 136
- Registration Number
- NCT06515990
- Locations
- 🇦🇺
ICON Cancer Center, South Brisbane, Queensland, Australia
News
No news found